Integra Lifesciences Holdings IART
NASDAQ IART
$14.53 +0.16 (+1.11%)
At close: Nov 10, 2026 · 4:00 PM EST

Integra Lifesciences Holdings (IART) EBITDA Margin (2009 - 2026)

Updated

Integra Lifesciences Holdings' EBITDA Margin came in at 14.36% for Q3 2026, up 1.52 percentage points from 12.83% a year earlier and up 0.40 percentage points from the prior quarter.

Analysis

Integra Lifesciences Holdings (IART) EBITDA Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Integra Lifesciences Holdings reported EBITDA Margin of 13.93%, up 33.64 percentage points year-over-year; for FY2025, it came in at -20.54%, down 31.40 percentage points from FY2024.

  • EBITDA Margin has declined in each of the last three years, with a five-year change of -40.92 percentage points (FY2020 to FY2025).
  • Going back by year, EBITDA Margin was 10.86% in FY2024 (-4.79 pp), 15.65% in FY2023 (-7.73 pp), 23.37% in FY2022 (+2.36 pp) and 21.01% in FY2021 (+0.64 pp).
  • The five-year range for quarterly EBITDA Margin is -113.83% (Q2 2025) to 24.99% (Q3 2022).
  • Year-over-year, EBITDA Margin has increased for three consecutive quarters, with an average year-over-year change of +1.58 percentage points over the last eight quarters.
  • The fastest year-over-year change in EBITDA Margin over five years came in Q2 2026 (a gain of 127.79 percentage points), and the weakest in Q2 2025 (a drop of 122.25 percentage points).
  • Business Quant data shows IART's EBITDA Margin at 13.96% (Q2 2026), 12.99% (Q1 2026) and 14.37% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn 25.44%
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn 20.09%
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn 30.00%
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn 25.90%
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn 25.55%
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn 20.38%
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn 23.14%
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn 20.05%
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn 24.62%
10 Integra Lifesciences Holdings 1.12 Bn 9.06 Mn 209.87 Mn 14.36%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.36%
Jun 30, 2026 13.96%
Mar 31, 2026 12.99%
Dec 31, 2025 14.37%
Sep 30, 2025 12.83%
Jun 30, 2025 -113.83%
Mar 31, 2025 6.03%
Dec 31, 2024 16.86%
Sep 30, 2024 7.65%
Jun 30, 2024 8.42%
Mar 31, 2024 9.74%
Dec 31, 2023 17.24%
Sep 30, 2023 15.32%
Jun 30, 2023 11.74%
Mar 31, 2023 18.23%
Dec 31, 2022 24.88%
Sep 30, 2022 24.99%
Jun 30, 2022 22.91%
Mar 31, 2022 20.61%
Dec 31, 2021 22.36%
API Access

Integra Lifesciences Holdings EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IART&period=max&api_key=YOUR_API_KEY